Apheresis collection parameters for approved CAR T‐cell products need to be standardized

Documenti analoghi

• Manufacturing and clinical applications of non‐ CAR ‐T immune effector cells
  di: Thane Kubik, et al.
  Pubblicazione: (2026)
• Apheresis procedures for the treatment of patients and for the collection of cellular therapy products: A British Society for Haematology guideline
  di: Catherine Howell, et al.
  Pubblicazione: (2025)
• Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy
  di: Nilu Perera, et al.
  Pubblicazione: (2024)
• Pediatric autologous peripheral blood stem cell collection without heparin using a highly concentrated sodium citrate anticoagulant: A retrospective comparison with standard ACD ‐A
  di: Keiko Fujii, et al.
  Pubblicazione: (2026)
• Increasing use of CAR‐T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6‐year period: Resource utilization implications
  di: Aswath P. Chandrasekar, et al.
  Pubblicazione: (2025)